These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10934775)

  • 1. [Multiple myeloma with hyperammonemia].
    Horie A; Watanabe T; Miyauchi Y; Irabu T; Yoshida S
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1433-4. PubMed ID: 10934775
    [No Abstract]   [Full Text] [Related]  

  • 2. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia.
    Matsuzaki H; Matsuno F; Yoshida M; Hata H; Okazaki K; Takatsuki K
    Intern Med; 1992 Mar; 31(3):339-43. PubMed ID: 1611184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemia and encephalopathy in patients with multiple myeloma.
    Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G
    Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
    Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
    Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study of multiple myeloma associated with hyperammonemia].
    Fujii S; Fukuda S; Sezaki T; Murakami M
    Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
    Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
    Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro excess ammonia production in human myeloma cell lines.
    Otsuki T; Yamada O; Sakaguchi H; Ichiki T; Kouguchi K; Wada H; Hata H; Yawata Y; Ueki A
    Leukemia; 1998 Jul; 12(7):1149-58. PubMed ID: 9665203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amino acid disturbance in multiple myeloma with hyperammonemia.
    Matsuzaki H; Hata H; Sonoki T; Matsuno F; Kuribayashi N; Yoshida M; Nagasaki A; Murata H; Fujiyama S; Takatsuki K
    Int J Hematol; 1995 Apr; 61(3):131-7. PubMed ID: 7599324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
    Minauchi K; Fujie T; Matsubara N; Kasahara H; Ogura Y; Tamura M; Yamane Y; Tanaka M; Taneichi K
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):139-41. PubMed ID: 14968586
    [No Abstract]   [Full Text] [Related]  

  • 12. A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy.
    Takimoto Y; Imanaka F; Hayashi Y; Morioka S
    Leukemia; 1996 May; 10(5):918-9. PubMed ID: 8656690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non-secretory primary plasma cell leukemia with hyperammonemia].
    Kawano F; Tsukamoto A; Satoh M; Sanada I; Shido T; Miura K; Murakami T; Kaneko H; Takeya M; Matsuzaki H
    Rinsho Ketsueki; 1991 Apr; 32(4):399-403. PubMed ID: 2067085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral edema induced by hyperammonemia: a case report.
    Yonai R; Sato R; Nasu M
    Am J Emerg Med; 2016 Dec; 34(12):2461.e3-2461.e5. PubMed ID: 27269953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple myeloma with hyperammonemia].
    Izumi T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):446-8. PubMed ID: 9851186
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.
    Gaiani A; Pompanin S; Zambello R; Briani C; Cagnin A
    Neurol Sci; 2017 Mar; 38(3):503-505. PubMed ID: 27718015
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-excretory myeloma.
    Cereda JM; Ayres J; Gibson T
    Br Med J (Clin Res Ed); 1982 Sep; 285(6343):715-6. PubMed ID: 6809205
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
    Ikewaki J; Ogata M; Imamura T; Kohno K; Nakayama T; Kadota J
    Leuk Lymphoma; 2009 Apr; 50(4):667-9. PubMed ID: 19373670
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic hyperammonemia after high-dose chemotherapy.
    Fine P; Adler K; Gerstenfeld D
    Am J Med; 1989 May; 86(5):629. PubMed ID: 2712077
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non secreting multiple myeloma].
    Magallares López B; Peralta Ginés C; Meriño Ibarra E; Sierra Monzón JL; Delgado Beltrán C
    Reumatol Clin; 2011; 7(2):145-6. PubMed ID: 21794801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.